Sadao Nagaoka
Biographic Data
| ID | 6914777 |
|---|---|
| NAME | Sadao Nagaoka |
| GIVEN NAMES | Sadao |
| FAMILY NAME | Nagaoka |
| SIGNATURE | NAGAOKA S |
| AFFILIATIONS | Tokyo Keizai University |
| ORCID | 0000-0002-9291-5763 |
| VERIFIED | Yes |
| TOTAL WORKS | 8 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 7 |
| WORKS AS EDITOR | 1 |
| FIRST PUBLICATION YEAR | 2010 |
| LATEST PUBLICATION YEAR | 2019 |
| H-INDEX | 0 |
Drug Discovery in Japan
Tocilizumab (Actemra, RoActemra)
Rosuvastatin (Crestor)
Nivolumab (Opdivo)
Compactin
CompactinCompactin was a breakthrough discovery made by Dr. Akira Endo of Sankyo Co., Ltd. Its discovery enabled the creation of a class of drugs (statins) for hyperlipidemia that effectively and safely lowers cholesterol through competitive inhibition of HMG-CoA reductaseHMG-CoA reductase. This chapter discusses the four major factors that contributed to this breakthrough discovery: (1) the uniqueness of the discovery program, (2) the adoption o…
Pravastatin (Pravachol, Mevalotin)
Global Spread of Pharmaceutical Patent Protection
We investigate the global spread of pharmaceutical patent protection as acquired by firms, based on a novel global patent database for all significant medical drugs, including biologics, introduced in Japan. It gives us the propensity of filing and grant rate for each country for patents granted in Japan. The major findings of the study are as following. Both the filing propensity to and the grant rate of major Asian countries approached those of…
Patent Statistics as an Innovation Indicator
No prominent works on this page.
Patent Statistics as an Innovation Indicator
Global Spread of Pharmaceutical Patent Protection
We investigate the global spread of pharmaceutical patent protection as acquired by firms, based on a novel global patent database for all significant medical drugs, including biologics, introduced in Japan. It gives us the propensity of filing and grant rate for each country for patents granted in Japan. The major findings of the study are as following. Both the filing propensity to and the grant rate of major Asian countries approached those of…
Drug Discovery in Japan
Tocilizumab (Actemra, RoActemra)
Rosuvastatin (Crestor)
Nivolumab (Opdivo)
Compactin
CompactinCompactin was a breakthrough discovery made by Dr. Akira Endo of Sankyo Co., Ltd. Its discovery enabled the creation of a class of drugs (statins) for hyperlipidemia that effectively and safely lowers cholesterol through competitive inhibition of HMG-CoA reductaseHMG-CoA reductase. This chapter discusses the four major factors that contributed to this breakthrough discovery: (1) the uniqueness of the discovery program, (2) the adoption o…
Pravastatin (Pravachol, Mevalotin)
Business (5 works) · Medicine (5 works) · Biology (4 works) · Internal Medicine (4 works) · Political science (4 works) · Bioinformatics (3 works) · Drug (3 works) · Law (3 works) · Lipoproteins and Cardiovascular Health (3 works) · Pharmacology (3 works)